Study guide

Effective-Dose Estimates and Diagnostic Reference Levels

NMTCB CT

Track your progress as you read

Finished sections get a check mark.

1 CT System Hardware & X-Ray Generation

X-Ray Tube Design and Focal Spots Tube Heat Loading, Bearings and Cooling Beam Filtration and Collimation Scanner Generations and Source/Detector Geometry Detector Technology & Data Acquisition Systems (DAS)

2 Gantry Mechanics & Ancillary Systems

Gantry Architecture, Clearance and Centering Slip Rings, Couch Motion and Load Safety Power Injector Hardware and Safety DICOM, Worklists and Image Archiving

3 Data Acquisition & Scanning Geometries

Axial vs. Helical Scanning & Pitch Mechanics Localizer/Scout Scans & Isocenter Alignment Beam Geometry, Slice Collimation & Data Sampling

4 Mathematical Reconstruction & Image Processing

Projection Data, Image Matrices and Voxel Sampling Filtered Back Projection and Reconstruction Kernels Iterative Reconstruction & AI-Powered Algorithms Hounsfield Unit Scale, Linear Attenuation & Windowing (WW/WL)

5 3D Visualization & Advanced Post-Processing

Multiplanar Reformation (MPR) & Curved Planar Reformation (CPR) Volume Rendering, Maximum/Minimum Intensity Projections & Virtual Endoscopy

6 Image Quality & Performance Metrics

Spatial Resolution, Modulation Transfer Function & Matrix Parameters MTF and Spatial-Resolution Testing Contrast Resolution, Quantum Noise & Temporal Resolution Interdependence of Image Quality Parameters & Radiation Dose

7 CT Artifacts Identification & Correction

Physics-Based Artifacts: Beam Hardening, Cupping & Partial Volume Averaging Equipment & Patient Artifacts: Ring, Motion, Metal & Windmill Effects

8 Quality Assurance & Routine Testing

Daily Quality Control: Water Calibration, Noise & Field Uniformity Periodic Quality Assurance: ACR Phantom Testing & Geometry Verification

9 Patient Communication, Screening & Preparation

Patient Identification, Clinical Screening & Pregnancy Protocols Informed Consent, Pre-Scan Fasting & Anxiety Management Patient Monitoring, Vital Signs Assessment & ECG Gating Setup

10 Infection Control & Medical Emergency Response

Infection Control, Aseptic Technique & Scanner Disinfection Medical Emergencies in the CT Suite: Vasovagal Reactions, Seizures & Code Protocols

11 Contrast Media Chemistry & Administration

Iodinated Contrast Properties: Osmolality, Viscosity & Molecular Structure Contrast Volume, Flow, Duration and Iodine Delivery Intravenous Access, Catheter Gauges & Power Injection Protocols Bolus Tracking, Test Bolus & Contrast Transit Dynamics

12 Non-Vascular Contrast & Adverse Reactions

Oral, Rectal and Enteral Contrast Intrathecal, Intra-articular and Cavitary Contrast Renal Impairment, CI-AKI Risk & Metformin Management Contrast Reactions: Categorization, Prophylaxis & Emergency Treatment

13 Neuroimaging & Head/Neck CT Protocols

Routine Brain and Trauma CT Technique Stroke, Hemorrhage and Targeted Skull-Base CT Facial Bones, Orbits & High-Resolution Temporal Bones Soft Tissue Neck & Paranasal Sinuses Protocols

14 Thoracic & Cardiovascular CT Protocols

Routine Chest CT: Pulmonary Parenchyma & Mediastinal Anatomy High-Resolution CT (HRCT) for Diffuse Interstitial Lung Disease Pulmonary Embolism & Cardiac CT Protocols

15 Abdominal & Pelvic CT Protocols

Multiphase Liver, Pancreas & Renal CT Protocols Gastrointestinal CT: Enterography, Colonography & Acute Abdomen Pelvic Cross-Sectional Anatomy & Gynecologic/Urologic Pathology

16 Musculoskeletal, Vascular & Interventional CT

Cervical, Thoracic and Lumbosacral Spine CT Extremity, Joint and Orthopedic Hardware CT CT Angiography (CTA): Carotid, Aortic & Peripheral Runoff Protocols CT-Guided Interventions: Biopsy, Abscess Drainage & Procedural Safety

17 Hybrid PET/CT and SPECT/CT Procedures

PET/CT Anatomy, Physiology and Attenuation Correction SPECT/CT Anatomy, Physiology and Attenuation Correction

18 Radiation Biology & Dose Descriptors

Radiation Physics, Cellular Interactions & Biological Risk Models Tissue Reactions, Stochastic Risk and Justification CTDI Measurement and Phantom References CTDI Weighting, Pitch and DLP Calculations Size-Specific Dose Estimates Effective-Dose Estimates and Diagnostic Reference Levels

19 Radiation Protection & Dose Optimization

Technical Dose Reduction: Tube Current Modulation & Pediatric ALARA Pediatric, Body-Habitus and Pregnancy Optimization Personnel Protection, Distance and Shielding Jurisdiction, Dose Limits and Personnel Monitoring

Effective-Dose Estimates and Diagnostic Reference Levels

Key Takeaways Explain This Topic AI

Effective dose is a reference-person protection quantity.

DLP conversion coefficients depend on region and model.

A diagnostic reference level is not an individual legal dose limit.

Last updated: October 2026

Effective dose and diagnostic reference levels

Effective dose is a tissue-weighted reference-population quantity used in radiation protection and broad exposure comparison. It differs from SSDE, which is expressed in mGy and concerns dose in the scanned region. Effective dose is expressed in mSv and should not be presented as a precise probability of cancer for an individual patient.

A practical approximate method multiplies DLP by a regional conversion coefficient, often written k. The coefficient's units cancel mGy·cm to leave mSv. Its applicability depends on anatomy, patient age or model, reference phantom and the underlying dosimetry and tissue-weighting system. There is no universal k for every CT study.

Arithmetic using explicitly stated coefficients

For an illustrative head study with CTDIvol 56 mGy and length 18 cm, DLP = 56 × 18 = 1008 mGy·cm. If the exercise supplies a historical adult head coefficient of 0.0021 mSv/(mGy·cm), the estimated effective dose is 1008 × 0.0021 = 2.1168 mSv, rounded to 2.12 mSv. That is a calculation under the supplied model, not a precise measurement of that patient's risk.

For a chest example, CTDIvol 11.5 mGy over 32 cm gives 368 mGy·cm. Using a supplied historical coefficient of 0.014 gives 5.152 mSv, rounded to 5.15 mSv. The different coefficients reflect the region and the model, not a rule that a lower DLP always means a lower effective dose across different anatomy.

These coefficients are historical AAPM Report 96 examples. More appropriate contemporary or indication-specific methods may give different estimates. Do not mix an older coefficient with newer tissue-weighting factors and imply that the combination is a single validated model. Use the stated inputs for exam arithmetic and an appropriately selected model for actual dose assessment.

Multiphase and mixed-region studies

Additional acquisitions add exposure. For separate series in the same appropriately modeled region, sum their relevant DLP contributions before applying the matching coefficient when that approach is valid. For a study spanning substantially different regions, one coefficient may be a poor approximation; a physicist or validated organ-dose method can provide a more suitable assessment.

A diagnostic chest CT and an attenuation-correction CT in a hybrid examination may serve different tasks and use different settings. The CT dose record must include the relevant events. The radiopharmaceutical contribution is assessed separately; it is not embedded in CTDIvol or DLP. Likewise, CT fluoroscopy's repeated local acquisitions should not be hidden by reporting only the final volumetric series.

Diagnostic reference levels are investigation benchmarks

A diagnostic reference level (DRL) helps identify unusually high typical exposures for a defined clinical task and patient group. It is commonly set at the 75th percentile of a relevant distribution of facility median dose indices. An achievable dose is often the median benchmark in a specified dataset. Definitions and datasets should be identified rather than treated as universal numerical limits.

A DRL is not a legal ceiling for an individual patient's examination and does not guarantee that every result below it is optimized. A large patient or complex task may reasonably need more exposure. Conversely, a very low value can accompany inadequate image quality. Review clinical task, size and quality together before changing a protocol.

Match the comparison before judging the result

Compare the same indication, age or size group, region, phantom reference and dose-index definition. A pediatric chest reference cannot be applied directly to an adult brain scan. An accreditation pass/fail dose criterion is also a different type of requirement from a DRL. Clearly label which comparison is being made.

If a facility's typical values exceed a matched DRL, investigate phase count, range, exposure settings, positioning and reconstruction with the responsible team. A single high value does not establish malpractice or mandate repeating the examination. Documentation should identify the reason and any protocol correction.

  • Question Appropriate quantity or comparison
  • Scanner output under a reference condition CTDIvol with phantom identified
  • Regional size-adjusted dose estimate SSDE with method identified
  • Broad protection comparison Effective-dose estimate with model identified
  • Typical protocol outlier investigation Matched DRL and image-quality review
  • Communicate estimates without false precision

Natural-background comparisons can provide context, but exposure varies geographically and the biological distribution differs from a CT examination. Avoid claiming that a scan is exactly equivalent to a fixed number of days for every patient. Explain that the figures are approximate and relate them to why the examination was needed.

A useful report preserves the actual indices, range, phase count and calculation method. That record permits a later reassessment with a better model. An unlabeled effective-dose number copied from a generic table cannot provide the same evidence.

References: AAPM Report 96 , FDA DRL and optimization explanation .